Recruiting Ph 2 Elacestrant in ER Positive Uterine Sarcomas NCT07467772 Conditions Adenosarcoma of the uterus, ESS, Endometrial Neoplasms, +25 more Locations Dana Farber Cancer Institute — Boston, Massachusetts, United States View Trial Details
Completed FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study NCT03926936 Conditions Adenosarcoma of Uterus, Adenosarcoma of the uterus, Endometrial Cancer, +24 more Locations CHU de Liege — Grivegnée, Liège, Belgium UZ Antwerp — Edegem, Belgium UZ Gent — Ghent, Belgium AZ Sint Maarten — Mechelen, Belgium View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
